ATE283693T1 - Verwendung von pregabalin zur asthma behandlung - Google Patents
Verwendung von pregabalin zur asthma behandlungInfo
- Publication number
- ATE283693T1 ATE283693T1 AT01121804T AT01121804T ATE283693T1 AT E283693 T1 ATE283693 T1 AT E283693T1 AT 01121804 T AT01121804 T AT 01121804T AT 01121804 T AT01121804 T AT 01121804T AT E283693 T1 ATE283693 T1 AT E283693T1
- Authority
- AT
- Austria
- Prior art keywords
- pregabalin
- asthma treatment
- asthma
- mammals
- relates
- Prior art date
Links
- 208000006673 asthma Diseases 0.000 title abstract 3
- AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical compound CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 title 1
- 229960001233 pregabalin Drugs 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- 208000027866 inflammatory disease Diseases 0.000 abstract 2
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23482700P | 2000-09-22 | 2000-09-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE283693T1 true ATE283693T1 (de) | 2004-12-15 |
Family
ID=22882992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01121804T ATE283693T1 (de) | 2000-09-22 | 2001-09-11 | Verwendung von pregabalin zur asthma behandlung |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20020058706A1 (de) |
| EP (1) | EP1192944B1 (de) |
| JP (1) | JP2002114675A (de) |
| KR (1) | KR20020023675A (de) |
| AT (1) | ATE283693T1 (de) |
| AU (1) | AU7217201A (de) |
| CA (1) | CA2356829A1 (de) |
| DE (1) | DE60107516D1 (de) |
| HU (1) | HUP0103812A2 (de) |
| IL (1) | IL145452A0 (de) |
| ZA (1) | ZA200107814B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE41920E1 (en) | 1996-07-24 | 2010-11-09 | Warner-Lambert Company Llc | Isobutylgaba and its derivatives for the treatment of pain |
| CA2451267A1 (en) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
| NL2000281C2 (nl) | 2005-11-02 | 2007-08-07 | Pfizer Prod Inc | Vaste farmaceutische samenstellingen die pregabaline bevatten. |
| EP2415460A1 (de) * | 2010-08-03 | 2012-02-08 | ratiopharm GmbH | Orale Darreichungsform von Pregabalin |
| EP2615913A4 (de) * | 2010-09-17 | 2014-03-19 | Panacea Biotec Ltd | Pregabalinhaltige pharmazeutische zusammensetzungen mit verzögerter freisetzung |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6197819B1 (en) * | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
| WO1992009560A1 (en) * | 1990-11-27 | 1992-06-11 | Northwestern University | Gaba and l-glutamic acid analogs for antiseizure treatment |
| USRE41920E1 (en) * | 1996-07-24 | 2010-11-09 | Warner-Lambert Company Llc | Isobutylgaba and its derivatives for the treatment of pain |
| EP0974351A3 (de) * | 1998-04-24 | 2000-12-13 | Jouveinal | Arzneimittel zur Vorbeugung und Behandlung von Magendarmschäden |
| AU3735000A (en) * | 1999-05-05 | 2000-11-21 | Warner-Lambert Company | Modulation of substance p by gaba analogs and methods relating thereto |
-
2001
- 2001-09-10 CA CA002356829A patent/CA2356829A1/en not_active Abandoned
- 2001-09-11 DE DE60107516T patent/DE60107516D1/de not_active Expired - Lifetime
- 2001-09-11 EP EP01121804A patent/EP1192944B1/de not_active Expired - Lifetime
- 2001-09-11 AT AT01121804T patent/ATE283693T1/de not_active IP Right Cessation
- 2001-09-13 IL IL14545201A patent/IL145452A0/xx unknown
- 2001-09-14 US US09/952,447 patent/US20020058706A1/en not_active Abandoned
- 2001-09-18 AU AU72172/01A patent/AU7217201A/en not_active Abandoned
- 2001-09-21 HU HU0103812A patent/HUP0103812A2/hu unknown
- 2001-09-21 JP JP2001288508A patent/JP2002114675A/ja active Pending
- 2001-09-21 ZA ZA200107814A patent/ZA200107814B/xx unknown
- 2001-09-22 KR KR1020010058865A patent/KR20020023675A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2356829A1 (en) | 2002-03-22 |
| ZA200107814B (en) | 2003-03-24 |
| EP1192944B1 (de) | 2004-12-01 |
| IL145452A0 (en) | 2002-06-30 |
| AU7217201A (en) | 2002-03-28 |
| EP1192944A1 (de) | 2002-04-03 |
| KR20020023675A (ko) | 2002-03-29 |
| HUP0103812A2 (hu) | 2002-12-28 |
| US20020058706A1 (en) | 2002-05-16 |
| DE60107516D1 (de) | 2005-01-05 |
| JP2002114675A (ja) | 2002-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60114580D1 (de) | Verwendung von cyanochinolinen zur behandlung oder inhibierung von dickdarmpolypen | |
| DK2298338T3 (da) | Lactoferrin-sammensætninger og fremgangsmåder til behandling af hudsår | |
| ATE522229T1 (de) | Anti-ngf-antikörper zur behandlung verschiedener erkrankungen | |
| DE60216122D1 (de) | Cysteinprotease-hemmer mit 2-cyano-4-amino-pyrimidinstruktur und cathepsin-k-hemmender wirkung zur behandlung von entzündungen und anderen erkrankungen | |
| ATE241358T1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
| ATE416761T1 (de) | Prävention und behandlung von durch entzündung ausgelöstem und/oder immunvermitteltem knochenschwund | |
| DE60143061D1 (de) | Verwendung von Botulinum Toxin zur Behandlung von Gelenkschmerzen | |
| ATE207356T1 (de) | Verwendung von tiagabin zur behandlung von schlafstörungen | |
| DE69532804D1 (de) | Verwendung von hemmern des maillard-reaktion zur behandlung von krankheiten zufolge amyloidosis | |
| DE69929464D1 (de) | Zyklische polyamine zur behandlung der thrombozytopenie | |
| DE60115872D1 (de) | Cabergolin zur behandlung von fibromyalgie und chronic-fatigue-syndrom | |
| DE69519577D1 (de) | Prednisolonmetasulfobenzoatzusammensetzung zur behandlung von entzündungserkrankung des darmes | |
| ATE413375T1 (de) | Retinoide zur behandlung von emphysem | |
| DE69638281D1 (de) | Anti-Interleukin-9 Antikörper oder Anti-Interleukin-9 Rezeptor Antikörper zur Behandlung von bronchialem Hyperreaktionsvermögen | |
| DE50209015D1 (de) | NEUE VERWENDUNG VON 2-Ä2-Ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenylÜ-5-methyl-7-propyl-3H-imidazoÄ5,1-fÜÄ1,2,4Ütriazin-4-on | |
| DE69943089D1 (de) | Methode zur behandlung von staphylokokkeninfektionen | |
| ATE473277T1 (de) | Zusammensetzungen und verfahren zur prävention und behandlung von immunvermittelten entzündungskrankheiten | |
| DE50105735D1 (de) | Chlorzoxazon zur behandlung von psoriasis | |
| DE60107516D1 (de) | Verwendung von Pregabalin zur Asthma Behandlung | |
| ATE359808T1 (de) | Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma | |
| ATE294584T1 (de) | Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz | |
| DE60144493D1 (de) | Verfahren zur bestimmung und behandlung von tuberöse-sklerose komplex assoziierten erkrankungen | |
| DE69827387D1 (de) | Verwendung von pramipexol zur behandlung von restless-legs-syndrom | |
| ATE287713T1 (de) | Verwendung von riluzol zur behandlung multipler sklerose | |
| DE60219761D1 (de) | Verwendung von quetiapin für die behandlung von kokain-abhängigkeit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |